Sort   by:  
 Page size 
UnknownComplex polypharmacy in bipolar disorder: Side effect burden, adherence, and response predictors.
Not available
S-EPMC6711795 | biostudies-literature
UnknownChildhood trauma and treatment outcomes during mood-stabilising treatment with lithium or quetiapine among outpatients with bipolar disorder.
Not available
S-EPMC9310642 | biostudies-literature
UnknownComplexity of illness and adjunctive benzodiazepine use in outpatients with bipolar I or II disorder: results from the Bipolar CHOICE study.
Not available
S-EPMC6557444 | biostudies-literature
UnknownEffect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial.
Not available
S-EPMC4113323 | biostudies-literature
UnknownAssociation study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia.
Not available
S-EPMC3401899 | biostudies-literature
UnknownThe International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders.
Not available
S-EPMC4091043 | biostudies-literature
UnknownSARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials.
Not available
S-EPMC11117088 | biostudies-literature
UnknownClinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials.
Not available
S-EPMC10346130 | biostudies-literature
UnknownRisk of COVID-19 after natural infection or vaccination.
Not available
S-EPMC10518569 | biostudies-literature
Sort   by:  
 Page size